Volume 1, Issue 1, January 2008
Next article
Table of contents
- Introduction By Jean-Pierre Després, PhD, FAHA, Editor-in-Chief page 2
- Editorial By Philippe Pibarot, DVM, PhD, FACC, FAHA, Guest Editor pages 3-4
- Molecular mechanisms of insulin resistance in obesity By André Marette, PhD pages 5-9
- The visceral adipocyte and cardiometabolic risk factors By André Tchernof, PhD pages 10-13
- Serum insulin and inflammatory markers in overweight people with and without dyslipidemia By Philip Barter, MBBS, FRACP, PhD pages 14-16
- Cardiometabolic risk: the surgeon's perspective By Patrick Mathieu, MD Philippe Pibarot, DVM, PhD, FACC, FAHA Jean-Pierre Després, PhD, FAHA pages 17-20
- "Valvulo-metabolic" risk in aortic stenosis By Philippe Pibarot, DVM, PhD, FACC, FAHA pages 21-25
